(KN) Knowles Cor - Overview
Stock: Capacitors, RF Filters, Microphones, Speakers, Medtech
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 32.1% |
| Relative Tail Risk | -15.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.07 |
| Alpha | 22.80 |
| Character TTM | |
|---|---|
| Beta | 1.459 |
| Beta Downside | 1.227 |
| Drawdowns 3y | |
|---|---|
| Max DD | 38.00% |
| CAGR/Max DD | 0.50 |
Description: KN Knowles Cor January 15, 2026
Knowles Corporation (NYSE:KN) designs and manufactures electronic components-including capacitors, RF/microwave filters, balanced-armature speakers, and med-tech microphones-serving OEMs and their supply chains across Asia, the United States, Europe, and the rest of the Americas. The business is split into two segments: Precision Devices (PD), which supplies ceramic, film, electrolytic and mica capacitors plus RF filtering for power supplies, medical implants, satellite communications and defense radar; and Medtech & Specialty Audio (MSA), which produces balanced-armature speakers and microphones for hearing-health, consumer audio and true-wireless stereo applications.
In FY 2023 Knowles reported revenue of roughly $1.1 billion, with the PD segment contributing about 62 % of sales and MSA the remaining 38 %. Key growth drivers include the accelerating adoption of electric vehicles (which boost demand for high-reliability capacitors), the rollout of 5G infrastructure (fueling RF filter orders), and a steady 4-5 % CAGR in the global hearing-aid market. Defense spending trends also support the RF filtering business, while the True Wireless Stereo segment benefits from continued consumer preference for ear-bud form factors. However, the company’s exposure to cyclical OEM demand and semiconductor supply constraints introduces material upside-down risk.
For a deeper, data-driven assessment of Knowles’ valuation dynamics, you may find ValueRay’s analyst toolkit useful as a next step.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 39.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -4.44 > 1.0 |
| NWC/Revenue: 27.59% < 20% (prev 45.46%; Δ -17.87% < -1%) |
| CFO/TA 0.09 > 3% & CFO 101.9m > Net Income 39.3m |
| Net Debt (104.5m) to EBITDA (95.6m): 1.09 < 3 |
| Current Ratio: 1.90 > 1.5 & < 3 |
| Outstanding Shares: last quarter (87.3m) vs 12m ago -2.68% < -2% |
| Gross Margin: 40.77% > 18% (prev 0.40%; Δ 4037 % > 0.5%) |
| Asset Turnover: 50.76% > 50% (prev 46.97%; Δ 3.79% > 0%) |
| Interest Coverage Ratio: 5.41 > 6 (EBITDA TTM 95.6m / Interest Expense TTM 10.9m) |
Altman Z'' -2.71
| A: 0.15 (Total Current Assets 334.2m - Total Current Liabilities 176.0m) / Total Assets 1.09b |
| B: -0.54 (Retained Earnings -590.4m / Total Assets 1.09b) |
| C: 0.05 (EBIT TTM 59.0m / Avg Total Assets 1.13b) |
| D: -2.14 (Book Value of Equity -718.6m / Total Liabilities 336.4m) |
| Altman-Z'' Score: -2.71 = D |
Beneish M -3.03
| DSRI: 0.98 (Receivables 107.7m/105.7m, Revenue 573.5m/550.2m) |
| GMI: 0.98 (GM 40.77% / 39.97%) |
| AQI: 1.10 (AQ_t 0.55 / AQ_t-1 0.51) |
| SGI: 1.04 (Revenue 573.5m / 550.2m) |
| TATA: -0.06 (NI 39.3m - CFO 101.9m) / TA 1.09b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of KN shares?
Over the past week, the price has changed by +11.30%, over one month by +14.71%, over three months by +19.80% and over the past year by +45.37%.
Is KN a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the KN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.5 | -1.8% |
| Analysts Target Price | 26.5 | -1.8% |
| ValueRay Target Price | 28.7 | 6.4% |
KN Fundamental Data Overview February 04, 2026
P/E Forward = 11.9332
P/S = 3.765
P/B = 2.7829
P/EG = 1.12
Revenue TTM = 573.5m USD
EBIT TTM = 59.0m USD
EBITDA TTM = 95.6m USD
Long Term Debt = 104.0m USD (from longTermDebt, last quarter)
Short Term Debt = 76.1m USD (from shortTermDebt, last quarter)
Debt = 197.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 104.5m USD (from netDebt column, last quarter)
Enterprise Value = 2.26b USD (2.16b + Debt 197.0m - CCE 92.5m)
Interest Coverage Ratio = 5.41 (Ebit TTM 59.0m / Interest Expense TTM 10.9m)
EV/FCF = 27.67x (Enterprise Value 2.26b / FCF TTM 81.8m)
FCF Yield = 3.61% (FCF TTM 81.8m / Enterprise Value 2.26b)
FCF Margin = 14.26% (FCF TTM 81.8m / Revenue TTM 573.5m)
Net Margin = 6.85% (Net Income TTM 39.3m / Revenue TTM 573.5m)
Gross Margin = 40.77% ((Revenue TTM 573.5m - Cost of Revenue TTM 339.7m) / Revenue TTM)
Gross Margin QoQ = 43.23% (prev 40.85%)
Tobins Q-Ratio = 2.08 (Enterprise Value 2.26b / Total Assets 1.09b)
Interest Expense / Debt = 1.17% (Interest Expense 2.30m / Debt 197.0m)
Taxrate = 19.28% (4.30m / 22.3m)
NOPAT = 47.6m (EBIT 59.0m * (1 - 19.28%))
Current Ratio = 1.90 (Total Current Assets 334.2m / Total Current Liabilities 176.0m)
Debt / Equity = 0.26 (Debt 197.0m / totalStockholderEquity, last quarter 751.8m)
Debt / EBITDA = 1.09 (Net Debt 104.5m / EBITDA 95.6m)
Debt / FCF = 1.28 (Net Debt 104.5m / FCF TTM 81.8m)
Total Stockholder Equity = 752.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.48% (Net Income 39.3m / Total Assets 1.09b)
RoE = 5.22% (Net Income TTM 39.3m / Total Stockholder Equity 752.4m)
RoCE = 6.89% (EBIT 59.0m / Capital Employed (Equity 752.4m + L.T.Debt 104.0m))
RoIC = 5.06% (NOPAT 47.6m / Invested Capital 941.8m)
WACC = 10.42% (E(2.16b)/V(2.36b) * Re(11.29%) + D(197.0m)/V(2.36b) * Rd(1.17%) * (1-Tc(0.19)))
Discount Rate = 11.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.89%
[DCF Debug] Terminal Value 70.62% ; FCFF base≈105.1m ; Y1≈110.2m ; Y5≈128.5m
Fair Price DCF = 16.57 (EV 1.52b - Net Debt 104.5m = Equity 1.41b / Shares 85.2m; r=10.42% [WACC]; 5y FCF grow 5.32% → 2.90% )
EPS Correlation: -46.39 | EPS CAGR: -51.19% | SUE: -4.0 | # QB: 0
Revenue Correlation: -67.98 | Revenue CAGR: -10.76% | SUE: 0.04 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.22 | Chg30d=-0.050 | Revisions Net=-4 | Analysts=4
EPS next Year (2026-12-31): EPS=1.22 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=+11.6% | Growth Revenue=+5.9%